Viewing Study NCT04672460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-02-24 @ 1:16 AM
Study NCT ID: NCT04672460
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-11-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Solid Tumors View
None Ovarian Cancer View
None Breast Cancer View
None Prostate Cancer View
None NSCLC View
None Pancreatic Cancer View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PARP inhibitor View
None Talazoparib View
None Talzenna View
None BRCA mutation View
None ATM mutation View
None Pharmacokinetics View
None Bioequivalence View
None Bioavailability View
None Food effect View